[NA-4]Exon skipping therapeutic strategy using 2'-O,4'-C-ethylene-bridged nucleic acid (ENA) oligonucleotides
○Makoto Koizumi(Modality Research Laboratories, Daiichi Sankyo Co., Ltd.)
Password required to view
Abstract password authentication.
The password was sent to all registrants in email.
The password was sent to all registrants in email.
